Possible key microRNAs and corresponding molecular mechanisms for atrial fibrillation.


Journal

Anatolian journal of cardiology
ISSN: 2149-2271
Titre abrégé: Anatol J Cardiol
Pays: Turkey
ID NLM: 101652981

Informations de publication

Date de publication:
06 2020
Historique:
entrez: 2 6 2020
pubmed: 2 6 2020
medline: 10 4 2021
Statut: ppublish

Résumé

We aimed to find crucial microRNAs (miRNAs) associated with the development of atrial fibrillation (AF), and then try to elucidate the possible molecular mechanisms of miRNAs in AF. The miRNA microarray, GSE68475, which included 10 right atrial appendage samples from patients with persistent AF and 11 samples from patients with normal sinus rhythm, was used for the analysis. After data preprocessing, differentially expressed miRNAs were screened using limma. Target genes of miRNAs were predicted using miRWalk2.0. We then conducted functional enrichment analyses for miRNA and target genes. Protein-protein interaction (PPI) network and module analyses for target genes were performed. Finally, transcription factors (TFs)-target genes regulatory network was predicted and constructed. Seven genes, including CAMK2D, IGF2R, PPP2R2A, PAX6, POU3F2, YWHAE, and AP2A2, were targeted by TFs. Among these seven genes, CAMK2D (targeted by miR-31-5p), IGF2R (targeted by miR-204-5p), PAX6 (targeted by miR-223-3p), POU3F2 (targeted by miR-204-5p), YWHAE (targeted by miR-31-5p), and AP2A2 (targeted by miR-204-5p) belonged to the top 10 degree genes in the PPI network. Notably, MiR-204-5p, miR-31-5p, and miR-223-3p had more target genes. Besides, CAMK2D was enriched in some pathways, such as adrenergic signaling in cardiomyocytes pathway and cAMP signaling pathway. YWHAE was enriched in the Hippo signaling pathway. miR-31-5p played a crucial role in cardiomyocytes by targeting CAMK2D and YWHAE via cAMP and Hippo signaling pathways. miR-204 was involved in the progression of AF by regulating its target genes IGF2R, POU3F2, and AP2A2. On the other hand, miR-223-3p functioned in AF by targeting PAX6, which was associated with the regulation of apoptosis in AF. This study would provide a theoretical basis and potential therapeutic targets for the treatment of AF. (Anatol J Cardiol 2020; 23: 324-33).

Identifiants

pubmed: 32478689
doi: 10.14744/AnatolJCardiol.2020.39483
pmc: PMC7414246
doi:

Substances chimiques

MIRN31 microRNA, human 0
MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

324-333

Références

BMC Plant Biol. 2014 Jun 17;14:169
pubmed: 24939556
Drug Metab Dispos. 2010 Mar;38(3):415-21
pubmed: 19995889
Heart Rhythm. 2009 Dec;6(12):1810-1
pubmed: 19959134
Hum Mol Genet. 2006 Oct 1;15(19):2888-902
pubmed: 16923798
Cardiol Clin. 2014 Nov;32(4):485-94
pubmed: 25443231
Lancet. 2015 Feb 26;385 Suppl 1:S82
pubmed: 26312904
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Mol Cell Biol. 2012 Dec;32(24):5089-102
pubmed: 23071090
Nature. 2002 Jan 10;415(6868):219-26
pubmed: 11805846
Biom J. 2017 Mar;59(2):331-343
pubmed: 27983754
J Int Med Res. 2019 Aug;47(8):3580-3589
pubmed: 31218935
Circ J. 2016 May 25;80(6):1346-55
pubmed: 27180889
Exp Biol Med (Maywood). 2009 Jul;234(7):779-84
pubmed: 19429854
J Cardiovasc Magn Reson. 2012 Nov 30;14:83
pubmed: 23199362
Tohoku J Exp Med. 2006 Sep;210(1):1-9
pubmed: 16960339
Int J Cardiol. 2013 Sep 30;168(2):660-9
pubmed: 23623666
Cell Death Dis. 2014 Oct 30;5:e1503
pubmed: 25356872
Heart Vessels. 2018 Oct;33(10):1258-1265
pubmed: 29721673
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52
pubmed: 25352553
Med Sci Monit. 2016 Jun 24;22:2175-81
pubmed: 27341015
Genes Dev. 2001 Apr 1;15(7):839-44
pubmed: 11297508
Blood. 2009 Jan 22;113(4):784-92
pubmed: 18574025
Nat Methods. 2015 Aug;12(8):697
pubmed: 26226356
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Heart Rhythm. 2009 Dec;6(12):1802-9
pubmed: 19959133
Exp Biol Med (Maywood). 2010 Jul;235(7):862-8
pubmed: 20472714
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W741-8
pubmed: 15980575
Circ Res. 2006 Jun 23;98(12):1538-46
pubmed: 16728661
Circulation. 2010 Dec 7;122(23):2378-87
pubmed: 21098446
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Heart Rhythm. 2019 Jul;16(7):1080-1088
pubmed: 30654134
Am J Physiol Heart Circ Physiol. 2004 Sep;287(3):H1179-85
pubmed: 15072955
J Clin Invest. 2013 May;123(5):1939-51
pubmed: 23543060
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Thromb Res. 2010 Aug;126(2):e150-1
pubmed: 20163834
J Endocrinol. 2008 May;197(2):381-90
pubmed: 18434368
Eur J Cardiothorac Surg. 2017 Jan;51(1):73-78
pubmed: 27422887
Pharmacogenomics. 2015;16(10):1101-8
pubmed: 26249541
Protein J. 2012 Jan;31(1):75-83
pubmed: 22160327
Diabetes Metab Res Rev. 2010 Jan;26(1):40-9
pubmed: 20013939

Auteurs

Huili Zhang (H)

Department of Pharmacy, The Second People's Hospital of Xinxiang; Henan-China.

Guangming Yang (G)

Department of Emergency, The Second People's Hospital of Xinxiang; Henan-China.

Ning Zhong (N)

Department of Cardiovasology, The Second People's Hospital of Xinxiang; Henan-China.

Jun Shan (J)

Department of General Medicine, The Second People's Hospital of Xinxiang; Henan-China.

Xiaona Li (X)

Department of Pharmacy, The Second People's Hospital of Xinxiang; Henan-China.

Yanhai Wu (Y)

Department of Cardiovasology, The Second People's Hospital of Xinxiang; Henan-China.

Yazhou Xu (Y)

Henan Zhongping Genetic Technology Co., Ltd., Zhengzhou; Henan-China.

Ye Yuan (Y)

Henan Zhongping Genetic Technology Co., Ltd., Zhengzhou; Henan-China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH